Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132483) titled 'Exploring safety-optimized anticoagulation approaches for blood purification therapy in critically ill patients' on Sept. 15.
Study Type: Observational study
Study Design:
Case study
Primary Sponsor: THE FIRST PEOPLE'S HOSPITAL OF WENLING
Condition:
Acute kidney injury (AKI)
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2024-11-01
Target Sample Size: low-dose citrate with nafamostat group:1;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=307758
Published by HT Digital Content Services with permission from Health Daily Dig...